IBDEI07C ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=ALPHA ORDER (E)^6^17
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=ALPHA ORDER (F)^7^17
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=ALPHA ORDER (G)^8^17
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=ALPHA ORDER (H)^9^17
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=ALPHA ORDER (I)^10^17
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=ALPHA ORDER (K)^11^17
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=ALPHA ORDER (L)^12^17
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=ALPHA ORDER (M)^13^17
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=ALPHA ORDER (N)^14^17
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=ALPHA ORDER (O)^15^17
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=ALPHA ORDER (P)^16^17
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=ALPHA ORDER (R)^17^17
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=ALPHA ORDER (S)^18^17
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=ALPHA ORDER (T)^19^17
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=ALPHA ORDER (U)^20^17
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=ALPHA ORDER (V)^21^17
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=ALPHA ORDER (X)^22^17
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=V CODES^23^17
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=NEW PATIENT^2^18
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=ESTABLISHED PATIENT^1^18
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=CONSULTATIONS^3^18
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=NEURO^5^19
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=MENTAL HEALTH^4^19
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=HISTORY OF ILLNESS^3^19
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^6^19
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^7^19
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=OTHER REASONS^8^19
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=TBI SCREENING^1^19
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^9^19
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=HEADACHES^2^19
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=IMMUNIZATIONS^5^20
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=PT/KT/OT^7^20
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=TESTING^8^20
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^20
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=COUNSELING^2^20
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=EDUCATION^3^20
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=INJECTIONS^6^20
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=ACUPUNTURE^1^20
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=IMMUNIZATION^3^21
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^21
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=COUNSELING RISK FACTOR REDUCTION^2^21
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=OTH PREVENTIVE MEDICINE SERVICES^4^21
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=PREVENTIVE MEDICINE,GROUP^7^21
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=PREVENTIVE HEALTH VISIT-EST PT^5^21
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=PREVENTIVE HEALTH VISIT-NEW PT^6^21
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=CARDIOVASCULAR^2^22
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=ENDOCRINE/METABOLIC^6^22
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=PULMONARY^19^22
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=EENT^5^22
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=MUSCULOSKELETAL^14^22
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=NEURO^15^22
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=MENTAL HEALTH^13^22
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=GASTROENTEROLOGY^7^22
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=GU / RENAL^8^22
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=WOMEN'S HEALTH^21^22
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=HEMATOLOGY/ONCOLOGY^9^22
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=INFECTIOUS DISEASE^11^22
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=DERMATOLOGY^4^22
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=HISTORY OF ILLNESS^10^22
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^1^22
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=INJURY/TRAUMA^12^22
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^22
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=SEXUAL TRAUMA^19^22
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=PAIN^17^22
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=OTHER REASONS^16^22
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^3^22
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=NEW PATIENT^2^23
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=ESTABLISHED PATIENT^1^23
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=CONSULTATIONS^3^23
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=IMMUNIZATION^6^24
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=INJECTION^7^24
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=SKIN TEST^15^24
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=NURSING PROCEDURES^9^24
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=MINOR PROCEDURES^8^24
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=SPLINTS^16^24
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=EDUCATION/TRAINING^3^24
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=ALLERGY SHOTS^1^24
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=EKG^4^24
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^2^24
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^10^24
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=GYN PROCEDURES^5^24
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=PREVENTIVE MED-EST PT^12^24
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=PREVENTIVE MED-NEW PT^13^24
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=RISK FACTOR REDUCTION^14^24
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=PREVENTIVE GROUP COUNSELING^11^24
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=CARDIOVASCULAR^3^25
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=ENDOCRINE/METABOLIC^7^25
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=PULMONARY^22^25
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=EENT^6^25
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=MUSCULOSKELETAL^17^25
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=NEURO^18^25
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=MENTAL HEALTH^16^25
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=GASTROENTEROLOGY^8^25
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=GU/RENAL^9^25
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=WOMEN'S HEALTH^25^25
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=HEMATOLOGY/ONCOLOGY^10^25
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=INFECTIOUS DISEASE^12^25
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=DERMATOLOGY^5^25
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=HISTORY OF ILLNESS^11^25
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=INJURY/TRAUMA^13^25
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^24^25
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=SEXUAL TRAUMA^23^25
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=PAIN^20^25
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=OTHER REASONS^19^25
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=COMMON DIAGNOSES^2^25
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=PREVENTIVE MEDICINE CODES^21^25
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^25
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^4^25
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=MAJOR DEPRESSION^15^25
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=LEGAL BLINDNESS^14^25
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=BLOODS, ARTERIAL & VENOUS^1^26
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=OXIMETRY (WHEN ONLY SERVICE)^6^26
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=PULMONARY FUNCTION TESTING^7^26
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=THORACENTESIS^9^26
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=RESPIRATORY THERAPY^8^26
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=BRONCHOSCOPY^2^26
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=EXERCISE TESTING^3^26
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^26
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=IMMUNIZATIONS^5^26
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=NEW PATIENT^2^27
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=ESTABLISHED PATIENT^1^27
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=CONSULTATIONS^3^27
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=SIGNS & SYMPTOMS^1^28
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=ENDOCRINE & METABOLIC^5^28
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=HEMATOLOGIC & LYMPHATIC^9^28
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=EYES, EARS & NOSE^6^28
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=VASCULAR^27^28
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=MUSCULOSKELETAL^13^28
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=GENITOURINARY & RENAL^8^28
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=CARDIAC^3^28
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=INTERSTITIAL LUNG DISEASES^12^28
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=OCCUPATIONAL^16^28
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=OTHER^17^28
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=PLEURAL DISEASE^19^28
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=INFECTIOUS DISEASES^11^28
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^28
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=GASTROINTESTINAL^7^28
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=HEPATIC & BILIARY^10^28
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=NEUROLOGIC^14^28
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=SKIN^24^28
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=PSYCHIATRIC & BEHAVIORAL^21^28
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=CANCER^2^28
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=RADIATION^22^28
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=SKELETAL^23^28
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=PAIN^18^28
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=SUTURES/DRESSINGS^26^28
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=COMPLICATIONS^4^28
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=SLEEP DISORDERS^25^28
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=PULMONARY^20^28
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=ESOPHAGUS^4^29
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=LYMPH NODES (SECONDARY)^6.5^29
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=LARYNX^6.4^29
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=LUNG^6.41^29
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=MELANOMA^6.6^29
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=GENITOURINARY^.5^29
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=BRAIN^.7^29
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=BREAST-FEMALE^.6^29
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=HYPOPHARYNX^6.1^29
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=CONNECTIVE & SOFT TISSUE^2^29
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=RADIATION FOLLOW-UP^.45^29
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=MOUTH^8^29
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=MOUTH-FLOOR^9^29
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=NASOPHARYNX^10^29
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=OROPHARYNX^11^29
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=PANCREAS^12^29
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=RECTUM/ANUS^13^29
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=SALIVARY GLANDS^14^29
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=SECONDARY MALIGNANT NEOPLASMS^15^29
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=TONGUE^16^29
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=MISCELLANEOUS^18^29
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;=BENIGN NEOPLASMS^.47^29
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;=RADIATION TREATMENT^.2^29
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;=PERSONAL HISTORY CA^19^29
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;=FOLLOW-UP^2^30
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=CONSULTATIONS^1^30
